Search Results - Rizzardini G

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines by Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G

Connect to this object online.

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatm... by Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D

Connect to this object online.

Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy by Rizzardini G, Bonfanti P, Carenzi L, Coen M, Orlando G, Di Matteo S, Colombo GL

Connect to this object online.

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile? by Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

Connect to this object online.

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service by Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

Connect to this object online.

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort by Tontodonati M, Cenderello G, Celesia BM, Trezzi M, Ursini T, Costantini A, Marra D, Polilli E, Catalani C, Butini L, Sozio F, Mazzotta E, Sciacca A, Rizzardini G, Manzoli L, Cozzi-Lepri A, Parruti G

Connect to this object online.